Cargando…
Establishment of a new bovine leukosis virus producing cell line
Due to the prevalence of different bovine leukosis virus (BLV) species in the cattle population in Europe, problems may arise in the serological diagnosis of BLV infections. In addition, earlier investigations demonstrated that contamination of the BLV antigen-producing cell culture systems by bovin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112874/ https://www.ncbi.nlm.nih.gov/pubmed/15381362 http://dx.doi.org/10.1016/j.jviromet.2004.06.017 |
_version_ | 1783513562228981760 |
---|---|
author | Beier, D. Riebe, R. Blankenstein, P. Starick, E. Bondzio, A. Marquardt, O. |
author_facet | Beier, D. Riebe, R. Blankenstein, P. Starick, E. Bondzio, A. Marquardt, O. |
author_sort | Beier, D. |
collection | PubMed |
description | Due to the prevalence of different bovine leukosis virus (BLV) species in the cattle population in Europe, problems may arise in the serological diagnosis of BLV infections. In addition, earlier investigations demonstrated that contamination of the BLV antigen-producing cell culture systems by bovine viral diarrhea virus (BVDV) may give rise to misinterpretation of serological test results after BVDV vaccination of cattle. By co-cultivation of peripheral leukocytes of a BLV-infected cow with a permanent sheep kidney cell line, a new BLV-producing cell line named PO714 was established. This line carries a BLV provirus of the Belgian species and has been tested to be free of a variety of possibly contaminating viruses and mycoplasms. Investigations of a panel of well-characterised sera by agar gel immunodiffusion (AGID) and capture ELISA (cELISA) tests using antigen prepared from this new cell line in comparison with antigen of the well-known cell line FLK/BLV yielded comparable results. False positive results caused by BVDV cross-reactions could be eliminated when tests were carried out with antigen derived from the new cell line. |
format | Online Article Text |
id | pubmed-7112874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71128742020-04-02 Establishment of a new bovine leukosis virus producing cell line Beier, D. Riebe, R. Blankenstein, P. Starick, E. Bondzio, A. Marquardt, O. J Virol Methods Article Due to the prevalence of different bovine leukosis virus (BLV) species in the cattle population in Europe, problems may arise in the serological diagnosis of BLV infections. In addition, earlier investigations demonstrated that contamination of the BLV antigen-producing cell culture systems by bovine viral diarrhea virus (BVDV) may give rise to misinterpretation of serological test results after BVDV vaccination of cattle. By co-cultivation of peripheral leukocytes of a BLV-infected cow with a permanent sheep kidney cell line, a new BLV-producing cell line named PO714 was established. This line carries a BLV provirus of the Belgian species and has been tested to be free of a variety of possibly contaminating viruses and mycoplasms. Investigations of a panel of well-characterised sera by agar gel immunodiffusion (AGID) and capture ELISA (cELISA) tests using antigen prepared from this new cell line in comparison with antigen of the well-known cell line FLK/BLV yielded comparable results. False positive results caused by BVDV cross-reactions could be eliminated when tests were carried out with antigen derived from the new cell line. Elsevier B.V. 2004-11 2004-08-17 /pmc/articles/PMC7112874/ /pubmed/15381362 http://dx.doi.org/10.1016/j.jviromet.2004.06.017 Text en Copyright © 2004 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Beier, D. Riebe, R. Blankenstein, P. Starick, E. Bondzio, A. Marquardt, O. Establishment of a new bovine leukosis virus producing cell line |
title | Establishment of a new bovine leukosis virus producing cell line |
title_full | Establishment of a new bovine leukosis virus producing cell line |
title_fullStr | Establishment of a new bovine leukosis virus producing cell line |
title_full_unstemmed | Establishment of a new bovine leukosis virus producing cell line |
title_short | Establishment of a new bovine leukosis virus producing cell line |
title_sort | establishment of a new bovine leukosis virus producing cell line |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112874/ https://www.ncbi.nlm.nih.gov/pubmed/15381362 http://dx.doi.org/10.1016/j.jviromet.2004.06.017 |
work_keys_str_mv | AT beierd establishmentofanewbovineleukosisvirusproducingcellline AT rieber establishmentofanewbovineleukosisvirusproducingcellline AT blankensteinp establishmentofanewbovineleukosisvirusproducingcellline AT staricke establishmentofanewbovineleukosisvirusproducingcellline AT bondzioa establishmentofanewbovineleukosisvirusproducingcellline AT marquardto establishmentofanewbovineleukosisvirusproducingcellline |